JP2009520696A - 出血性ショックおよびその続発症を治療するための製剤 - Google Patents

出血性ショックおよびその続発症を治療するための製剤 Download PDF

Info

Publication number
JP2009520696A
JP2009520696A JP2008546020A JP2008546020A JP2009520696A JP 2009520696 A JP2009520696 A JP 2009520696A JP 2008546020 A JP2008546020 A JP 2008546020A JP 2008546020 A JP2008546020 A JP 2008546020A JP 2009520696 A JP2009520696 A JP 2009520696A
Authority
JP
Japan
Prior art keywords
pro
arg
gly
peptide
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008546020A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520696A5 (cg-RX-API-DMAC7.html
Inventor
ペッチェルバオアー，ペーター
ヘニング，ライナー
Original Assignee
ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー filed Critical ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー
Publication of JP2009520696A publication Critical patent/JP2009520696A/ja
Publication of JP2009520696A5 publication Critical patent/JP2009520696A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2008546020A 2005-12-23 2006-11-10 出血性ショックおよびその続発症を治療するための製剤 Pending JP2009520696A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0206705A AT502987A1 (de) 2005-12-23 2005-12-23 Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen
PCT/AT2006/000465 WO2007070899A2 (de) 2005-12-23 2006-11-10 Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen

Publications (2)

Publication Number Publication Date
JP2009520696A true JP2009520696A (ja) 2009-05-28
JP2009520696A5 JP2009520696A5 (cg-RX-API-DMAC7.html) 2009-12-24

Family

ID=37846035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546020A Pending JP2009520696A (ja) 2005-12-23 2006-11-10 出血性ショックおよびその続発症を治療するための製剤

Country Status (14)

Country Link
US (1) US7897574B2 (cg-RX-API-DMAC7.html)
EP (2) EP1962887B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009520696A (cg-RX-API-DMAC7.html)
KR (1) KR20080108221A (cg-RX-API-DMAC7.html)
CN (1) CN101365477A (cg-RX-API-DMAC7.html)
AT (2) AT502987A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006326890A1 (cg-RX-API-DMAC7.html)
CA (1) CA2634026A1 (cg-RX-API-DMAC7.html)
DE (1) DE502006004619D1 (cg-RX-API-DMAC7.html)
ES (1) ES2331970T3 (cg-RX-API-DMAC7.html)
IL (1) IL192349A0 (cg-RX-API-DMAC7.html)
NO (1) NO20083191L (cg-RX-API-DMAC7.html)
RU (1) RU2008130413A (cg-RX-API-DMAC7.html)
WO (1) WO2007070899A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021066691A (ja) * 2019-10-24 2021-04-30 国立大学法人東海国立大学機構 慢性肺疾患／急性呼吸窮迫症候群の治療薬

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101389653A (zh) * 2006-02-23 2009-03-18 菲布雷克斯医疗研究及开发有限责任公司 肽和肽衍生物以及含有它们的药物组合物
EP2193370A2 (en) * 2007-09-24 2010-06-09 Fibrex Medical Research & Development GmbH Methods of screening for compounds having anti-inflammatory activity
US20130324469A1 (en) * 2010-12-09 2013-12-05 The Brigham And Women's Hospital, Inc. Fibrinogen and kidney damage
US20170112941A1 (en) * 2015-10-13 2017-04-27 Symic Ip, Llc Ve-cadherin binding bioconjugate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004527469A (ja) * 2000-12-12 2004-09-09 ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー ペプチドおよび／またはタンパク質、並びにその治療用および／または予防用医薬成分を調製するための使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997844A (en) 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US20080311103A1 (en) 2004-03-08 2008-12-18 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Anti-Inflammatory Peptides and Methods of Use Thereof
AT414097B (de) 2004-06-25 2006-09-15 Petzelbauer Peter Dr Pharmazeutische zubereitung zur behandlung von schock
WO2006000007A1 (de) 2004-06-25 2006-01-05 Fibrex Medical Research & Development Gesmbh Verwendung von peptiden, die aus der a alpha oder der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004527469A (ja) * 2000-12-12 2004-09-09 ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー ペプチドおよび／またはタンパク質、並びにその治療用および／または予防用医薬成分を調製するための使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6011021259; 日本外科学会雑誌 第１０４巻，第１２号, 2003, ｐ．８３５-８３９ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021066691A (ja) * 2019-10-24 2021-04-30 国立大学法人東海国立大学機構 慢性肺疾患／急性呼吸窮迫症候群の治療薬
JP7506364B2 (ja) 2019-10-24 2024-06-26 国立大学法人東海国立大学機構 慢性肺疾患／急性呼吸窮迫症候群の治療薬

Also Published As

Publication number Publication date
CN101365477A (zh) 2009-02-11
WO2007070899A2 (de) 2007-06-28
EP2110136A2 (de) 2009-10-21
AT502987A1 (de) 2007-07-15
AU2006326890A1 (en) 2007-06-28
IL192349A0 (en) 2008-12-29
US7897574B2 (en) 2011-03-01
DE502006004619D1 (de) 2009-10-01
KR20080108221A (ko) 2008-12-12
EP1962887B1 (de) 2009-08-19
ATE440282T1 (de) 2009-09-15
CA2634026A1 (en) 2007-06-28
EP2110136A3 (de) 2010-01-27
RU2008130413A (ru) 2010-01-27
WO2007070899A3 (de) 2007-10-04
NO20083191L (no) 2008-09-16
ES2331970T3 (es) 2010-01-21
EP1962887A2 (de) 2008-09-03
US20090005310A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
JP6878423B2 (ja) プラスミノーゲン欠損症のためのプラスミノーゲン補充療法
Bryant et al. Human plasma kallikrein-kinin system: physiological and biochemical parameters
JP5037331B2 (ja) 出血性障害の処置のための第ｉｘａ因子
Mohammadipoor et al. Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuli
US10617745B2 (en) Methods for preventing post-operative complications of cardiopulmonary surgery
JP2019527689A (ja) 鎌状赤血球症における血管閉塞性クリーゼ、急性肺障害、および／または急性呼吸窮迫症候群を治療、改善および／または予防するためのａｄａｍｔｓ１３の使用
JP2009520696A (ja) 出血性ショックおよびその続発症を治療するための製剤
US20080249006A1 (en) Pharmaceutical Preparation for the Treatment of Shock
US20110053851A1 (en) Haemostasis-modulating compositions and uses therefor
US20180319868A1 (en) Serpin reactive center loop peptides and methods of use
JP2007513881A (ja) Ｘｉ因子の治療学的使用
JP7515557B2 (ja) 凝固異常を伴う敗血症の治療及び／又は改善のための医薬
CN119684441B (zh) 一种衍生多肽pm6及其在抗血栓中的应用
JP4149208B2 (ja) 血栓の溶解を制御するペプチドおよびその利用
RU2799764C2 (ru) Лекарственное средство для терапевтического лечения и/или улучшения состояния при сепсисе, сопровождающемся коагулопатией
MX2008008324A (en) Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms
WO2026006884A1 (en) Modulators of fxii-upar
KR20190111912A (ko) 출혈의 치료 또는 예방에 사용하기 위한 혈액 응고 인자 대체품
CN109316599A (zh) 一种抑肽酶或其突变体、衍生物、类似物或其组成片段的应用
WO2008038777A1 (en) Therapeutic agent for disseminated intravascular coagulation syndrome
Albayrak Fibrinogen and Fibrin
HK1093308B (en) Use of peptides derived from the b beta chain of human fibrinogen for the treatment of shock

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120327

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20121120